Potential Catalysts For Pharmacy Stocks: Pfizer (PFE)

<p>Vamil Divan, Managing Director and Senior Healthcare Analyst at Mizuho, and Sel Hardy, Equity Analyst at CFRA Research, take a look at a pharmacy stocks, specifically Pfizer (PFE). Mizuho has a neutral rating on Pfizer and CFRA has a strong buy rating on Pfizer. They also discuss potential catalysts for pharmacy stocks. Tune in to find out more.</p>